Achieved Q1 2026 PEMGARDA® (pemivibart) net product revenue of $13.7 million, representing 22% growth versus Q1 2025 net product revenue of $11.3 millionInvivyd in vitro data showed continued neutrali ...
LAS VEGAS, May 11, 2026 (GLOBE NEWSWIRE) -- (OTC: BCBC) (“Bitcoin Bancorp” or the “Company”), the holder of foundational patents for Bitcoin ATMs, and one of only ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果